Alpa Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

114.49

-1.01 (-0.87%)

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology

114.49

-1.01 (-0.87%)
15:40 Dec 26

Quality

75/100
High Financial Strength

Valuation

59/100
Affordable Valuation

Technical

60/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	97.55	112.27	92.96	108.74	97.3
Operating Expenses +	89.85	101.6	84.88	100.64	87.5
Raw Material	60.62	69.24	53.67	68.68	54.58
Increase Decrease in Cost	-1.15	0.53	1.27	-0.64	0.46
Other Manufacturing Expense	5.29	6.31	6.55	6.57	0
Employee Cost	11.75	11.93	12.17	13.29	13.77
Miscellaneous Expenses	26.12	25.23	13.66	24.34	18.69
Operating Profit	7.7	10.67	8.08	8.1	9.8
Other Income	4.4	10.78	9.37	14.89	19.57
Depreciation	1.23	1.66	1.33	1.95	2.25
Interest	0.08	0.22	0.22	0.36	0.41
Profit before tax and exceptio..	10.79	19.56	15.89	20.68	26.71
Exceptional Items	0	0	0	0	0.04
PBT	10.79	19.56	15.89	20.68	26.67
Provision for Taxation	3.54	5.47	3.31	3.91	5.87
Net Profit	7.25	14.09	12.58	16.78	20.85
NET Profit after MI	7.25	14.09	12.58	16.78	20.85
EPS	3.44	6.7	5.88	8.01	9.96
Operating Profit Margin (%)	7.89	9.5	8.69	7.45	10.07
Net Profit Margin (%)	7.43	12.55	13.53	15.43	21.43

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	57.30	57.30	57.30	57.30	57.30
FII	0.70	0.40	0.50	1.00	0.10
MF	0.00	0.00	0.00	0.00	0.00
Public	42.00	42.40	42.20	41.70	42.60
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	-0.10	0.00	0.00	0.00